Cytosorbents CorporationCTSONASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank29
5Y CAGR-43.8%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-43.8%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20254.13%
202414.51%
2023-10.39%
2022-13.51%
20211.66%
202073.30%
201912.41%
201851.34%
201763.07%
2016102.33%